Primary mediastinal synovial sarcoma in an infant: A case report

Abstract

Background: Primary mediastinal synovial sarcoma (PMSS) is an uncommon and aggressive soft tissue tumor, particularly rare in infants. Its diagnosis is challenging due to overlapping features with other thoracic neoplasms and requires integration of histopathology, immunohistochemistry, and molecular genetics.

Case presentation: We present a case of a 4-month-old girl admitted with respiratory distress and found to have a large posterior mediastinal mass. Histopathology and immunohistochemistry were compatible with biphasic synovial sarcoma. However, molecular confirmation via detection of SS18-SSX fusion was not performed. Despite multimodal chemotherapy, the tumor progressed, and complete surgical resection was unachievable. The patient died during follow-up in the pediatric intensive care unit.

Conclusion: Accurate diagnosis is critically dependent on SS18-SSX molecular testing, particularly in infants. Incomplete resection and lack of genetic confirmation may contribute to poor prognosis. Literature supports that complete resection is the only consistent predictor of survival. This case illustrates the limitations and consequences of managing PMSS without molecular confirmation or complete resection. A multidisciplinary approach with current diagnostic standards is essential in these high-risk pediatric tumors.

Keywords

synovial sarcoma / mediastinal tumor / pediatric sarcoma

References

[1] Bae YJ , Kim H , Cha W , Choi BS . Primary pharyngeal synovial sarcoma in a pediatric patient: a case report. Medicine. 2021; 100 (52): e28411.

[2] Terra SBSP , Aesif SW , Maleszewski JJ , Folpe AL , Boland JM . Mediastinal synovial sarcoma: clinicopathologic analysis of 21 cases with molecular confirmation. Am J Surg Pathol. 2018; 42 (6): 761- 766.

[3] Syred K , Weissferdt A . Primary mediastinal synovial sarcomas. Mediastinum. 2020; 4: 13.

[4] Patel PB , Sankrith M , Cedeno-Rodriguez A . Pediatric pleuropulmonary synovial sarcoma: a case report in a recurrent spontaneous pneumothorax. Respir Med Case Rep. 2022; 36: 101622.

[5] Baranov E , McBride MJ , Bellizzi AM , et al. A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol. 2020; 44 (7): 922- 933.

[6] Goldblum JR , Folpe AL , Weiss S . Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Elsevier; 2014.

[7] Doyle LA . Sarcoma classification and molecular testing. Cancer. 2021; 127 (4): 607- 619.

[8] Blay JY , Mehren Mv , Jones RL , et al. ESMO Clinical Practice Guidelines. ESMO Open. 2023; 8 (1): 101618.

[9] Espinoza , AF , Shetty , PB , Jacobson , JC , et al. The impact of margins and re-resection in pediatric synovial sarcoma. Cancer Med. 2024; 13 (17): e70207.

RIGHTS & PERMISSIONS

The Author(s). Malignancy Spectrum published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.